IGC Pharma OverviewIGC Pharma EBIT
EBIT (Earnings Before Interest and Taxes) analysis for IGC.
Quarterly EBIT
-$2.46M
↓ 74.08% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$9.13M
↓ 22.55% YoY
Trailing 12 months ending Mar 31, 2026
IGC Pharma OverviewEBIT (Earnings Before Interest and Taxes) analysis for IGC.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026